Evidence map›Paper›PMID 34200947›Full record

ReviewMolecules (Basel, Switzerland)2021

Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications.

Luiz Gustavo de Almeida Chuffa, Fábio Rodrigues Ferreira Seiva, Adriana Alonso Novais, Vinícius Augusto Simão, Virna Margarita Martín Giménez, Walter Manucha, Debora Aparecida Pires de Campos Zuccari, Russel J Reiter

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Biopolymeric Scaffolds with Melatonin for Tissue Engineering-A Review.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Luiz Gustavo de Almeida ChuffaDepartment of Structural and Functional Biology, Institute of Biosciences, UNESP-São Paulo State University, Botucatu, São Paulo 18618-689, Brazil.ORCID 0000-0002-0199-3396
Fábio Rodrigues Ferreira SeivaBiological Science Center, Department of Biology, Luiz Meneghel Campus, Universidade Estadual do Norte do Paraná-UENP, Bandeirantes 86360-000, PR, Brazil.ORCID 0000-0002-7461-8773
Adriana Alonso NovaisHealth Sciences Institute, Federal University of Mato Grosso, UFMT, Sinop 78607-059, MG, Brazil.ORCID 0000-0002-3399-0202
Vinícius Augusto SimãoDepartment of Structural and Functional Biology, Institute of Biosciences, UNESP-São Paulo State University, Botucatu, São Paulo 18618-689, Brazil.ORCID 0000-0002-3915-2795
Virna Margarita Martín GiménezFacultad de Ciencias Químicas y Tecnológicas, Instituto de Investigaciones en Ciencias Químicas, Universidad Católica de Cuyo, Sede San Juan 5400, Argentina.
Walter ManuchaLaboratorio de Farmacología Experimental Básica y Traslacional. Área de Farmacología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina.ORCID 0000-0002-2279-7626
Debora Aparecida Pires de Campos ZuccariCancer Molecular Research Laboratory (LIMC), Department of Molecular Biology, FAMERP, São José do Rio Preto 15090-000, Brazil.
Russel J ReiterDepartment of Cell Systems and Anatomy, UT Health, San Antonio, TX 78229, USA.ORCID 0000-0001-6763-4225
Universidade Estadual Paulista (Unesp) · BRConsejo Nacional de Investigaciones Científicas y Técnicas · ARFaculdade de Medicina de São José do Rio Preto · BRThe University of Texas Health Science Center at San Antonio · USUniversidad Católica de Cuyo · ARUniversidade Estadual do Norte do Paraná · BRUniversidade Federal de Mato Grosso · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 304108/2020-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/00906-6
6 · The paper itself

Abstract

The use of nanosized particles has emerged to facilitate selective applications in medicine. Drug-delivery systems represent novel opportunities to provide stricter, focused, and fine-tuned therapy, enhancing the therapeutic efficacy of chemical agents at the molecular level while reducing their toxic effects. Melatonin (

Indexed as

AnimalsCircadian RhythmDrug CarriersDrug Delivery SystemsHumansMelatoninNanoparticlesNanostructuresPineal GlandDrug CarriersMelatonindrug-delivery systemmelatoninmelatonin-loaded nanocarriersnanocarriersnanoparticles

Identifiers

PMID34200947
PMCPMC8230720
OpenAlexW3169427662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.